Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility geneAlfons Meindl, Helmut Hanenberg, Juliane Ramser et al.|Nature Genetics|2010Cited by 734
BRCA1 and BRCA2 genetic testing—pitfalls and recommendations for managing variants of uncertain clinical significanceDiana Eccles, David E. Goldgar, Gillian Mitchell et al.|Annals of Oncology|2015Cited by 220
Gene panel testing of 5589 <i><scp>BRCA</scp>1/2</i>‐negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian CancerJan Hauke, Eric Hahnen, Judit Horváth et al.|Cancer Medicine|2018Cited by 168
Copy number variant in the candidate tumor suppressor gene MTUS1 and familial breast cancer riskBernd Frank, Barbara Burwinkel, Justo Lorenzo Bermejo et al.|Carcinogenesis|2007Cited by 101
Ovarian carcinoma patients with a tumor <i>BRCA</i> -like genomic copy number aberration profile benefit from maintenance olaparib/bevacizumab therapy in the PAOLA-1 randomized controlled trialPhilip C. Schouten, Rita K. Schmutzler|medRxiv|2023Cited by 0